documents: FDA-2026-N-1832-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-1832-0004 FDA FDA-2026-N-1832 GRAS Notice (GRN) 1294 - Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Notice General Notice 2026-04-28T04:00:00Z 2026 4 2026-04-28T04:00:00Z   2026-04-28T16:27:15Z   0 0 09000064b92a8cc7

Links from other tables